These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Propensity-score matched comparison of complications, blood transfusions, length of stay, and in-hospital mortality between open and laparoscopic partial nephrectomy: a national series. Sun M, Abdollah F, Shariat SF, Schmitges J, Trinh QD, Tian Z, Jeldres C, Abdo A, Bianchi M, Briganti A, Montorsi F, Perrotte P, Karakiewicz PI. Eur J Surg Oncol; 2012 Jan; 38(1):80-7. PubMed ID: 21996370 [Abstract] [Full Text] [Related]
7. The effect of gender on nephrectomy perioperative outcomes: a national survey. Sammon J, Trinh QD, Sun M, Bianchi M, Schmitges J, Shariat SF, Ghani KR, Sukumar S, Jeldres C, Briganti A, Perrotte P, Rogers CG, Peabody JO, Montorsi F, Menon M, Karakiewicz PI. Can J Urol; 2012 Aug; 19(4):6337-44. PubMed ID: 22892256 [Abstract] [Full Text] [Related]
8. Propensity-score-matched comparison of perioperative outcomes between open and laparoscopic nephroureterectomy: a national series. Hanna N, Sun M, Trinh QD, Hansen J, Bianchi M, Montorsi F, Shariat SF, Graefen M, Perrotte P, Karakiewicz PI. Eur Urol; 2012 Apr; 61(4):715-21. PubMed ID: 22209172 [Abstract] [Full Text] [Related]
9. A matched-cohort comparison of laparoscopic cryoablation and laparoscopic partial nephrectomy for treating renal masses. O'Malley RL, Berger AD, Kanofsky JA, Phillips CK, Stifelman M, Taneja SS. BJU Int; 2007 Feb; 99(2):395-8. PubMed ID: 17092288 [Abstract] [Full Text] [Related]
14. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology. Kassouf W, Sanchez-Ortiz R, Tamboli P, Tannir N, Jonasch E, Merchant MM, Matin S, Swanson DA, Wood CG. J Urol; 2007 Nov; 178(5):1896-900. PubMed ID: 17868729 [Abstract] [Full Text] [Related]
15. Population-based assessment of survival after cytoreductive nephrectomy versus no surgery in patients with metastatic renal cell carcinoma. Zini L, Capitanio U, Perrotte P, Jeldres C, Shariat SF, Arjane P, Widmer H, Montorsi F, Patard JJ, Karakiewicz PI. Urology; 2009 Feb; 73(2):342-6. PubMed ID: 19041122 [Abstract] [Full Text] [Related]
16. Cytoreductive nephrectomy for T4NxM1 renal cell carcinoma: the M.D. Anderson Cancer Center experience. Kassouf W, Sanchez-Ortiz R, Tamboli P, Jonasch E, Merchant MM, Spiess PE, Wood CG. Urology; 2007 May; 69(5):835-8. PubMed ID: 17482917 [Abstract] [Full Text] [Related]
17. Partial nephrectomy for renal masses ≥ 7 cm: technical, oncological and functional outcomes. Long CJ, Canter DJ, Kutikov A, Li T, Simhan J, Smaldone M, Teper E, Viterbo R, Boorjian SA, Chen DY, Greenberg RE, Uzzo RG. BJU Int; 2012 May; 109(10):1450-6. PubMed ID: 22221502 [Abstract] [Full Text] [Related]
18. Cytoreductive partial nephrectomy does not undermine cancer control in metastatic renal cell carcinoma: a population-based study. Capitanio U, Zini L, Perrotte P, Shariat SF, Jeldres C, Arjane P, Pharand D, Widmer H, Péloquin F, Montorsi F, Patard JJ, Karakiewicz PI. Urology; 2008 Nov; 72(5):1090-5. PubMed ID: 18799207 [Abstract] [Full Text] [Related]
19. The true risk of blood transfusion after nephrectomy for renal masses: a population-based study. Vricella GJ, Finelli A, Alibhai SM, Ponsky LE, Abouassaly R. BJU Int; 2013 Jun; 111(8):1294-300. PubMed ID: 23368715 [Abstract] [Full Text] [Related]